Outcomes of Twice Repeated High-Voltage Long-Duration Pulsed Radiofrequency Treatment in Subacute Postherpetic Neuralgia: a Retrospective Single-Center Analysis
DOI: https://doi.org/10.2147/jpr.s465251
IF: 2.8319
2024-06-12
Journal of Pain Research
Abstract:Huaichang Wen, 1, 2, &ast Yi Wang, 2, &ast Hao Cheng, 2 Bin Wang, 2 Xianwen Hu 1 1 Department of Anesthesiology, The Second Hospital of Anhui Medical University, Hefei, People's Republic of China; 2 Department of Anesthesiology, First Affiliated Hospital of Wannan Medical College, Wuhu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xianwen Hu, Department of Anesthesiology, The Second Hospital of Anhui Medical University, Hefei, 230032, People's Republic of China, Email Background: The treatment of herpes zoster-related pain is challenging, and requires a variety of methods including pulse radio frequency modulation. Among them, single-time high-voltage long-term pulsed radiofrequency (HL-PRF) has been proved to be an effective treatment for subacute postherpetic neuralgia. However, it has the possibility of poor long-term curative effect and recurrence of neuralgia. In this study, we aim to identify the clinical efficacy and safety of twice repeated HL-PRF treatment in patients with subacute postherpetic neuralgia. Design: We conducted a retrospective analysis of subacute postherpetic neuralgia patients who underwent HL-PRF treatment. Setting: Pain Management Department of First Affiliated Hospital of Wannan Medical College. Patients: We enrolled all patients with subacute postherpetic neuralgia, who underwent HL-PRF treatment from January 2023 to October 2023. Measurements: The primary outcome variable was the visual Analog Scale (VAS) scores at 1, 4, 8, and 12 weeks after treatment. Secondary outcomes included Pittsburgh sleep quality index (PSQI), 36-item short-form health survey (SF-36) score, and total effective rate after treatment. Results: A total of 63 patients were included in the analysis. Among them, 33 patients received single-time HL-PRF treatment (Group S) and 30 patients received twice repeated HL-PRF treatment (Group T). Pain scores, PSQI scores, and SF-36 score were reduced in both groups after treatment ( P < 0.001). Compared to group S, the VAS scores, PSQI scores, anxiety scores, and depression scores were significantly lower at 1, 4, 8, and 12 weeks in group T. ( P < 0.001). The total efficiency rate at 12 weeks after treatment of group T was statistically higher than that of group S (60.6% vs 86.7%, P < 0.05). Conclusion: Twice repeated high-voltage long-duration PRF therapy demonstrates satisfactory efficacy in patients with subacute postherpetic neuralgia and is associated with no significant adverse reactions. Keywords: herpes zoster, subacute postherpetic neuralgia, CT-guided, pulsed radiofrequency therapy, dorsal root ganglion Zoster-associated pain (ZAP) refers to the neuropathic pain persisting in patients with herpes zoster (HZ) before, during and after the rash heals. 1 Based on the duration of pain, ZAP is categorized into acute herpetic neuralgia (AHN) within the first month of herpes, subacute herpetic neuralgia (SHN) within three months after the acute phase, and postherpetic neuralgia (PHN), characterized by pain lasting for more than three months. 2,3 Current treatments for ZAP involve both drug therapy and minimally invasive interventional therapy. AHN can be effectively alleviated by early antiviral, oral analgesics, and nerve block. 4,5 However, once PHN develops, the available treatment methods are limited, and the effective rate of cure is also significantly reduced. 6 Therefore, the AHN/SHN is the key period of minimally invasive interventional therapy. Minimally invasive interventional therapy includes pulsed radiofrequency (PRF) technology and spinal cord stimulation, aiming to reduce the need for analgesic drugs and control pain effectively. 7 Although the traditional standard PRF (RF parameters: 42°C, 40V, 2Hz, 20ms, 120s) is widely used to treat postherpetic neuralgia, 8 its therapeutic effect is limited due to low action intensity and short field effect time. In comparison, HL-PRF has shown greater efficacy. 9 Yet, the long-term efficacy of single PRF in the treatment of postherpetic neuralgia is suboptimal. Studies suggest that repetitive standard PRF may outperform single standard PRF, demonstrating better early analgesic effects and reducing the incidence of clinically meaningful ZAP within the first month after treatment. 10 Therefore, our retrospective study aims to observe the clinical efficacy and safety of twice repeated HL-PRF treatment in patients with subacute postherpetic neuralgia and compare the outcomes with a single -Abstract Truncated-
clinical neurology